POMPANO BEACH, Fla., Dec. 19, 2023 (GLOBE NEWSWIRE) BioStem Technologies Inc. (OTC: BSEM), a leading regenerative medicine company focused on the development, manufacture, and commercialization of placental-derived biologics for
There's another Pappas working at Pappas Capital, but the venture capital firm is quick to point out that Nick Pappas is "no relation" to the firm's founder Art Pappas.
/PRNewswire/ Pappas Capital, a leading investor in next-generation life science and technology companies, announced today that Nick Pappas (no relation) has.